This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
International Flavors' (IFF) Q3 Earnings & Sales Lag Estimates
by Zacks Equity Research
International Flavors (IFF) records growth in operating margin and generates strong free cash flow, aided by productivity savings and acquisition-related synergies in Q3.
FEMSA Comercio Seals JV with Raizen, Expands Brazil Footprint
by Zacks Equity Research
FEMSA Comercio, a unit of FEMSA (FMX), closes the previously entered JV agreement with Raizen Conveniencias in Brazil, after receiving the necessary regulatory approvals.
Colgate (CL) Earnings Surpass Estimates in Q3, Sales Miss
by Zacks Equity Research
Colgate (CL) beats third-quarter 2019 earnings estimates on strong volume and pricing gains.
Avon (AVP) Q3 Earnings Beat Estimates, Sales Decline Y/Y
by Zacks Equity Research
Avon's (AVP) focus on pricing and productivity initiatives drives adjusted operating margin. Also, the company is progressing well with its "Open Up Avon" strategy.
Clorox (CLX) Beats Q1 Earnings Estimates, Sales Miss (Revised)
by Zacks Equity Research
Clorox (CLX) reports earnings beat in first-quarter fiscal 2020. However, sales miss estimates on higher trade promotional spending, unfavorable mix, and adverse currency rates.
Clorox (CLX) Beats Earnings & Sales Estimates in Q1 (revised)
by Zacks Equity Research
Clorox (CLX) reports first-quarter fiscal 2020 results on higher trade promotional spending and unfavorable mix as well as adverse currency rates.
Church & Dwight (CHD) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Church & Dwight's (CHD) Q3 earnings and sales improve on gains from most product categories.
Estee Lauder (EL) Stock Down Despite Q1 Earnings & Sales Beat
by Zacks Equity Research
The Estee Lauder's (EL) first-quarter fiscal 2020 results reflect strength in the Skin Care category, Estee Lauder brand, and travel retail and online channels.
Clorox (CLX) Falls Short Of Earnings & Sales Estimates in Q1
by Zacks Equity Research
Clorox (CLX) reports dismal first-quarter fiscal 2020 results on higher trade promotional spending and unfavorable mix as well as adverse currency rates.
Altria's (MO) Q3 Earnings & Revenues Up Y/Y on Solid Pricing
by Zacks Equity Research
Altria's (MO) performance in third-quarter 2019 gains from improved top-line performance, mainly driven by better pricing.
Hershey (HSY) Q3 Earnings In Line With Estimates, Sales Up
by Zacks Equity Research
Hershey's (HSY) Q3 results benefit from improved volumes and acquisitions. However, currency rates were a drag during the quarter.
Procter & Gamble (PG) Stock Rises on Q1 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble's (PG) sales and earnings beat estimates in Q1 on organic sales growth in all segments, margin expansion and cash productivity gains. It raises view for fiscal 2020.
Will Coty's (COTY) Robust Luxury Unit Revive the Stock?
by Zacks Equity Research
Coty (COTY) gains on advancements in its Luxury business and e-commerce platform. However, sluggishness in the Consumer and Professional Beauty segment is a worry.
Helen of Troy (HELE) Q2 Earnings & Sales Beat, Stock Down
by Zacks Equity Research
Helen of Troy Limited's (HELE) top and bottom lines increase year over year and beat the Zacks Consensus Estimate in Q2. However, the Health & Home segment looks troubled.
Will Input Costs Hurt Helen of Troy's (HELE) Q2 Earnings?
by Zacks Equity Research
Helen of Troy's (HELE) Q2 earnings are likely to be hurt by rising costs and weakness in the Personal Care business.
Helen of Troy Gains on Leadership Brands: Will Momentum Stay?
by Zacks Equity Research
Helen of Troy's (HELE) focus on Leadership Brands, sturdy digital efforts and Transformation Plan bode well. However, elevated costs and soft Personal Care business are concerning.
Avon (AVP) Launches Distillery Brand, Growth Plans Bode Well
by Zacks Equity Research
Avon (AVP) introduces Distillery, an innovative skincare and makeup brand.
International Flavors (IFF) Affiliate LMC Acquires Speximo
by Zacks Equity Research
International Flavors (IFF) & LMC's Speximo acquisition supports consumers' desire for products with a greener profile.
General Mills (GIS) Beats on Q1 Earnings, Sales Down Y/Y
by Zacks Equity Research
General Mills (GIS) Q1 results gain from growth in the pet segment. However, weakness in other units were a drag.
Tyson Foods Gains From Protein Packed Brands, Costs High
by Zacks Equity Research
Tyson Foods (TSN) is gaining from consistent growth in the Chicken and Beef units. However, rising input costs stemming from market volatilities are concerns.
Can Coty's (COTY) Strong Luxury Unit & E-commerce Pare Woes?
by vidya Nair
Coty (COTY) gains from continued advancements in the Luxury business and the digital platform. However, sluggishness in the Consumer Beauty segment is a worry.
Estee Lauder (EL) Up 44% in a Year: Factors Driving the Stock
by Zacks Equity Research
Estee Lauder (EL) focuses on enhancing travel retail business. Also, robust online network bodes well.
Zacks.com featured highlights include: Helen of Troy, SolarEdge, Kirkland and Royal Gold
by Zacks Equity Research
Zacks.com featured highlights include: Helen of Troy, SolarEdge, Kirkland and Royal Gold
Nu Skin Down 12% in 3 Months, Mainland China is a Concern
by Zacks Equity Research
Nu Skin (NUS) is battling headwinds in Mainland China, stemming from the government's campaign to scrutinize offerings of direct selling and health products industries.
4 Stocks With Momentum Anomaly to Buy Right Away
by Zacks Equity Research
Momentum stocks don't usually offer attractive entry points, as the trend they establish continues for some time. So, any major reversal in trend could be a solid buying opportunity.